MENU
AIM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
AIM ImmunoTech (AIM) Earnings Date & Reports
AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies... Show more
A.I. Advisor
published Earnings
AIM is expected to report earnings to fall 65.12% to -15 cents per share on November 17
Q3'26
Est.
$-0.15
Q2'26
Missed
by $0.14
Q1'26
Beat
by $7.31
Q4'25
Beat
by $6.61
Q3'25
Beat
by $6.43
The last earnings report on August 10 showed earnings per share of -43 cents, missing the estimate of -29 cents. With 730.79K shares outstanding, the current market capitalization sits at 7.22M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders
Industry Biotechnology
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
21
Web
https://www.aimimmuno.com